Non-structural role of cytokeratins in malignant neoplasms
- Authors: Boldyshevskaya M.A.1, Tashireva L.A.1, Andryukhova E.S.1, Dronova T.A.1, Vtorushin S.V.1,2, Perelmuter V.M.1
-
Affiliations:
- Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
- Siberian State Medical University
- Issue: Vol 10, No 4 (2023)
- Pages: 76-85
- Section: REVIEW
- Published: 15.12.2023
- URL: https://umo.abvpress.ru/jour/article/view/611
- DOI: https://doi.org/10.17650/2313-805X-2023-10-4-76-85
- ID: 611
Cite item
Full Text
Abstract
Cytokeratins (CKs) are well studied as intermediate filaments of the cytoskeleton of epithelial cells, providing specific cell structure and morphology, in particular, apico-basal cell polarization. Meanwhile, a certain specificity of the association of CK with different types of epithelia is noted. CK heterogeneity in the glandular epithelium is particularly pronounced and is associated with anatomical localization. The relative specificity of CKs in epithelium of different localization is preserved to a great extent in carcinomas originating from this epithelium as well. Due to this fact the determination of CK spectrum in tumor cells is quite an effective tool for nosological diagnostics of carcinomas. however, the function of CKs is not limited to providing the cell structure. The presence and amount of CK changes during the most important processes in normal and tumor cells: movement/invasion, apoptosis, proliferation, epithelial-mesenchymal plasticity.
A question arises: Is initiation of the above-listed processes happens first, and therefore CK changes are secondary and «passive», or in some processes CK changes can play a role of a trigger? Knowing the answer to this question is not only of fundamental importance, but is also important for finding ways to control the above processes by influencing the CKs.
About the authors
M. A. Boldyshevskaya
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Email: fake@neicon.ru
ORCID iD: 0000-0002-2399-4170
5 Kooperativny Line, Tomsk 634009
Russian FederationL. A. Tashireva
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Author for correspondence.
Email: tashireva@oncology.tomsk.ru
ORCID iD: 0000-0003-2061-8417
Liubov A. Tashireva.
5 Kooperativny Line, Tomsk 634009
Russian FederationE. S. Andryukhova
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Email: fake@neicon.ru
ORCID iD: 0000-0003-0909-9206
5 Kooperativny Line, Tomsk 634009
Russian FederationT. A. Dronova
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Email: fake@neicon.ru
ORCID iD: 0000-0003-3009-2404
5 Kooperativny Line, Tomsk 634009
Russian FederationS. V. Vtorushin
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences; Siberian State Medical University
Email: fake@neicon.ru
ORCID iD: 0000-0002-1195-4008
5 Kooperativny Line, Tomsk 634009; 2 Moskovsky Trakt, Tomsk 634050
Russian FederationV. M. Perelmuter
Cancer Research Institute of Tomsk National Research Medical Center of the Russian Academy of Sciences
Email: fake@neicon.ru
ORCID iD: 0000-0002-7633-9620
5 Kooperativny Line, Tomsk 634009
Russian FederationReferences
Supplementary files


